Mohammed VI University Hospital
11
0
1
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
ISGLT2 in Patients Without DM With Acute MI
Role: lead
Registry Initiative Across Borders for Atrial Fibrillation in Africa
Role: lead
Gap CO2 in Septic Patient to Predict Cardiomyopathy Septic
Role: lead
Awake Prone Positioning for COVID-19 Acute Hypoxaemic Respiratory Failure
Role: lead
Obesity: an Underappreciate Risk Factor for Severe Form of COVID-19
Role: lead
PLR in a Good Helath After 24 Week of Preganancy
Role: lead
Developing and Testing AI Models for Fetal Biometry and Amniotic Volume Assessment in Fetal Ultrasound Scans.
Role: collaborator
Place of Glycation in Diabetic Retinopathy
Role: lead
Outcome of ECMO and CRRT.
Role: lead
Procalcitonin Level and the High Risk of Mortality in 30 Days in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Patient , Cases Series.
Role: lead
Prone Position During ECMO in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Hypoxaemic Patient
Role: lead
All 11 trials loaded